Editorial: Endocrine aspects of Noonan syndrome and related syndromes, volume II.
作者信息
Mazzanti Laura, Tartaglia Marco, Radetti Giorgio
机构信息
Alma Mater Studiorum, University of Bologna, Bologna, Italy.
Molecular Genetics and Functional Genomics, Ospedale Pediatrico Bambino Gesù, IRCCS, Roma, Italy.
出版信息
Front Endocrinol (Lausanne). 2025 Feb 18;16:1566521. doi: 10.3389/fendo.2025.1566521. eCollection 2025.
Abstract
摘要
相似文献
1
Editorial: Endocrine aspects of Noonan syndrome and related syndromes, volume II.社论：努南综合征及相关综合征的内分泌方面，第二卷
Front Endocrinol (Lausanne). 2025 Feb 18;16:1566521. doi: 10.3389/fendo.2025.1566521. eCollection 2025.
2
Editorial: Endocrine aspects of Noonan syndrome and related syndromes.社论：努南综合征及相关综合征的内分泌方面
Front Endocrinol (Lausanne). 2023 Jan 5;13:1127686. doi: 10.3389/fendo.2022.1127686. eCollection 2022.
3
Impact of pubertal timing on growth progression and final height in subjects affected by RASopathies.青春期发育时间对患有RAS病患者生长进程和最终身高的影响。
Front Endocrinol (Lausanne). 2025 Jan 17;15:1531545. doi: 10.3389/fendo.2024.1531545. eCollection 2024.
4
Endocrinological manifestations in RASopathies.RAS 病中的内分泌表现。
Am J Med Genet C Semin Med Genet. 2022 Dec;190(4):471-477. doi: 10.1002/ajmg.c.32013. Epub 2022 Nov 19.
5
Lipid profile in Noonan syndrome and related disorders: trend by age, sex and genotype.努南综合征及相关疾病的脂质谱：按年龄、性别和基因型的趋势。
Front Endocrinol (Lausanne). 2023 Jul 31;14:1209339. doi: 10.3389/fendo.2023.1209339. eCollection 2023.
6
Pathogenesis of Growth Failure in Rasopathies.RAS病中生长发育迟缓的发病机制。
Pediatr Endocrinol Rev. 2019 May;16(Suppl 2):447-458. doi: 10.17458/per.vol16.2019.ad.pathogenesisrasopathies.
7
GH Therapy and first final height data in Noonan-like syndrome with loose anagen hair (Mazzanti syndrome).马赞蒂综合征（类努南综合征伴生长期毛发稀疏）患者的 GH 治疗和首次最终身高数据。
Am J Med Genet A. 2013 Nov;161A(11):2756-61. doi: 10.1002/ajmg.a.36255. Epub 2013 Oct 3.
8
Abnormalities of pubertal development and gonadal function in Noonan syndrome.努南综合征患者青春期发育和性腺功能异常。
Front Endocrinol (Lausanne). 2023 Jul 28;14:1213098. doi: 10.3389/fendo.2023.1213098. eCollection 2023.
9
Constitutional bone impairment in Noonan syndrome.努南综合征中的先天性骨骼损害。
Am J Med Genet A. 2017 Mar;173(3):692-698. doi: 10.1002/ajmg.a.38086.
10
Growth, Endocrine Features, and Growth Hormone Treatment in Noonan Syndrome.努南综合征的生长、内分泌特征及生长激素治疗
J Clin Med. 2022 Apr 5;11(7):2034. doi: 10.3390/jcm11072034.
本文引用的文献
1
Editorial: Endocrine aspects of Noonan syndrome and related syndromes.社论：努南综合征及相关综合征的内分泌方面
Front Endocrinol (Lausanne). 2023 Jan 5;13:1127686. doi: 10.3389/fendo.2022.1127686. eCollection 2022.
2
Endocrine system involvement in patients with RASopathies: A case series.RAS 相关疾病患者的内分泌系统受累：病例系列。
Front Endocrinol (Lausanne). 2022 Nov 18;13:1030398. doi: 10.3389/fendo.2022.1030398. eCollection 2022.
3
Inside the Noonan "universe": Literature review on growth, GH/IGF axis and rhGH treatment: Facts and concerns.努南“综合征”的相关研究：生长、GH/IGF 轴及 rhGH 治疗的文献回顾：事实与关注。
Front Endocrinol (Lausanne). 2022 Aug 18;13:951331. doi: 10.3389/fendo.2022.951331. eCollection 2022.
4
Growth in Children With Noonan Syndrome and Effects of Growth Hormone Treatment on Adult Height.努南综合征患儿的生长情况以及生长激素治疗对成年身高的影响。
Front Endocrinol (Lausanne). 2021 Dec 22;12:761171. doi: 10.3389/fendo.2021.761171. eCollection 2021.
5
GH Responsiveness in Children With Noonan Syndrome Compared to Turner Syndrome.与 Turner 综合征相比，Noonan 综合征患儿的 GH 反应性。
Front Endocrinol (Lausanne). 2021 Nov 9;12:737893. doi: 10.3389/fendo.2021.737893. eCollection 2021.
6
Etiology and Treatment of Growth Delay in Noonan Syndrome.努南综合征生长迟缓的病因与治疗。
Front Endocrinol (Lausanne). 2021 Jun 4;12:691240. doi: 10.3389/fendo.2021.691240. eCollection 2021.
Zotero 插件